Your browser doesn't support javascript.
loading
Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab.
Martens, Alexander; Wistuba-Hamprecht, Kilian; Yuan, Jianda; Postow, Michael A; Wong, Phillip; Capone, Mariaelena; Madonna, Gabriele; Khammari, Amir; Schilling, Bastian; Sucker, Antje; Schadendorf, Dirk; Martus, Peter; Dreno, Brigitte; Ascierto, Paolo A; Wolchok, Jedd D; Pawelec, Graham; Garbe, Claus; Weide, Benjamin.
Afiliação
  • Martens A; Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Internal Medicine II, University Medical Center, Tübingen, Germany.
  • Wistuba-Hamprecht K; Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Internal Medicine II, University Medical Center, Tübingen, Germany.
  • Yuan J; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Postow MA; Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York.
  • Wong P; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Capone M; Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy.
  • Madonna G; Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy.
  • Khammari A; Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France.
  • Schilling B; Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Sucker A; Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Schadendorf D; Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Martus P; Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany.
  • Dreno B; Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France.
  • Ascierto PA; Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy.
  • Wolchok JD; Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York.
  • Pawelec G; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, United Kingdom.
  • Garbe C; Department of Dermatology, University Medical Center, Tübingen, Germany.
  • Weide B; Department of Dermatology, University Medical Center, Tübingen, Germany. benjamin.weide@med.uni-tuebingen.de.
Clin Cancer Res ; 22(19): 4848-4858, 2016 Oct 01.
Article em En | MEDLINE | ID: mdl-27169993

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Ipilimumab / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Ipilimumab / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha